A detailed history of Dlk Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 1,953 shares of ABBV stock, worth $391,596. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,953
Previous 1,953 -0.0%
Holding current value
$391,596
Previous $335 Million 15.13%
% of portfolio
0.15%
Previous 0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

BUY
$137.6 - $154.97 $268,732 - $302,656
1,953 New
1,953 $303 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dlk Investment Management, LLC Portfolio

Follow Dlk Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dlk Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dlk Investment Management, LLC with notifications on news.